✦ LIBER ✦

PRESENCE OF TYPE 2 DIABETES SIGNIFICANTLY MODULATES THE CARDIOVASCULAR RISK CONFERRED BY THE PLASMINOGEN ACTIVATOR INHIBITOR-1 -675 5G/4G POLYMORPHISM

✍ Scribed by Saely, C.H.; Muendlein, A.; Vonbank, A.; Aczel, S.; Marte, T.; Rein, P.; Risch, L.; Drexel, H.

Book ID: 118635854
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 74 KB
Volume: 9
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(08)70011-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type 2 diabetes significantly modulates

Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 − 675 4G/5G polymorphism in angiographied coronary patients

✍ Christoph H. Saely; Axel Muendlein; Alexander Vonbank; Gudrun Sonderegger; Stefa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 272 KB

The effect of the plasminogen activator

The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk

✍ Argirios E. Tsantes; Georgios K. Nikolopoulos; Pantelis G. Bagos; Stefanos Bonov 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 165 KB

The plasminogen activator inhibitor-1 (P

The plasminogen activator inhibitor-1 (PAI-1) gene −844 A/G and −675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome

✍ Sun Lin; Zhang Huiya; Liu Bo; Wei Wei; Guan Yongmei 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 219 KB

4G/5G polymorphism of the plasminogen ac

4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting

✍ Corinna Böttiger; Werner Koch; Christina Lahn; Julinda Mehilli; Nicolas von Beck 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 111 KB

The 4G/5G polymorphism of the type 1 pla

The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome

✍ Dolors Tàssies; Gerard Espinosa; Francisco Jose Muñoz-Rodríguez; Carolina Freire 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Objective: To investigate the relationship between the 4g/5g polymorphism of the type 1 plasminogen activator inhibitor (pai-1) gene and thrombotic manifestations in patients with antiphospholipid syndrome (aps). ## Methods: We studied a total of 247 patients included in the following 4 groups

The 4G/4G polymorphism of the hypofibrin

The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: An independent risk factor for serious pregnancy complications

✍ C.J. Glueck; Harvey Phillips; Dan Cameron; Ping Wang; Robert N. Fontaine; Sarah 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 228 KB